Legal & Regulatory in M&A: The Framework Every Seller Must Understand

A sale of a bankrupt company's assets under Section 363 of the US Bankruptcy Code — approved by the bankruptcy court and providing the buyer with assets free of most pre-existing liens and claims. Named for the code section authorizing it, 363 sales allow buyers to acquire assets with substantially reduced liability risk (no successor liability from the estate). Common in distressed M&A where time is critical and clean asset transfer is needed. The bankruptcy trustee or DIP lender often serves as the effective seller.

Government review of M&A transactions for anticompetitive effects — conducted by the FTC and DOJ under Hart-Scott-Rodino filing requirements for deals above statutory thresholds. Most SMB deals don't trigger formal antitrust review; transactions in concentrated industries or by large serial acquirers face closer scrutiny. See [HSR Act](#hsr-act-hart-scott-rodino) for full treatment.

The definitive legal contract that governs an asset sale — specifying which assets are acquired, which liabilities are assumed, the purchase price, and the post-close protections for both sides.

Appraisal Rights is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

Arbitration Provision is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

Assignment of Contracts is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

The Committee on Foreign Investment in the United States — an interagency body that reviews acquisitions of US businesses by foreign buyers for national security implications. CFIUS can recommend the President block a deal, require divestitures of sensitive assets, or impose operating conditions (mitigation agreements). Filing is mandatory for certain transactions involving foreign government ownership; voluntary for others. Deals in defense, semiconductors, critical infrastructure, sensitive personal data, and advanced technology face the highest scrutiny. Processing time: 30-45 days for standard review, up to 90 days for full investigation.

Consent Requirements is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

A contractual restriction in the purchase agreement preventing the seller from competing with the sold business for a defined period, geography, and scope — standard in M&A and generally enforceable when the buyer is paying for goodwill.

Exhibits to the purchase agreement that list specific exceptions to the seller's representations and warranties — effectively defining the actual scope of what the seller is promising.

Dissenting Shareholders is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

Entire Agreement Clause is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

A federal law requiring advance notification to the FTC and DOJ for M&A transactions above certain size thresholds — triggering a mandatory waiting period for antitrust review before closing.

Lease Assumption is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

Licensing Transfer is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

A contractual provision permitting a buyer to terminate a signed deal before closing if the target business experiences a significantly negative change — difficult to invoke successfully in court, but critical protection against catastrophic changes.

A contract provision restricting the seller (and often key employees) from competing with the acquired business after closing — defined by geography, time period, and scope of competing activity.

Non-disparagement Clause is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

Observer Rights is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

The governing document for a limited liability company (LLC) defining member rights, ownership percentages, management authority, distribution policies, transfer restrictions, and exit provisions. In M&A, operating agreements are a primary diligence document for LLC acquisitions — revealing ownership structure, change-of-control restrictions, member consent requirements, and preemptive rights. Missing or informal operating agreements are a red flag that can delay deals.

Pre-emptive Rights is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

Proxy Statement is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

Government authorizations required before specific M&A transactions can close. Common categories: antitrust/competition (HSR Act filings for deals above thresholds), financial services (banking regulators for financial institution acquisitions), healthcare (state healthcare authority approvals for hospital, physician practice, or insurance deals), foreign investment (CFIUS review when foreign parties are involved), and professional licensing (state board approvals for licensed business transfers). Missing regulatory approvals is a closing condition failure.

Reverse Breakup Fee is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

Right of First Offer (ROFO) is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

Rule 144 is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

Shareholder Approval is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

An independent committee of disinterested board members formed to evaluate and negotiate an M&A transaction when conflicts of interest exist — most commonly in management buyouts (MBOs), going-private transactions, or deals involving a controlling shareholder on one side of the transaction. Special committees provide independent oversight to protect minority shareholders and demonstrate fair dealing to reduce litigation risk. Common in public companies; increasingly used in private companies with institutional investors and minority shareholders.

A legal remedy compelling a party to perform specific contractual obligations — in M&A, forcing a buyer to close a signed deal rather than simply paying damages. Specific performance is increasingly common in private M&A because monetary damages may be inadequate to compensate a seller for a failed transaction (the seller may have turned down other buyers, and the business may be difficult to resell quickly). Sellers negotiating definitive agreements often seek explicit specific performance rights; buyers sometimes resist or limit it with a reverse termination fee as an alternative remedy.

Stalking Horse Bid is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

The definitive agreement for a stock sale transaction — governing the purchase of equity interests in the target company. The SPA covers: representations and warranties, covenants (pre-close and post-close), closing conditions, purchase price mechanics, indemnification framework, and dispute resolution. Distinct from an APA (which governs asset sales). Stock sales use SPAs; asset sales use APAs. See full treatment at [APA (Asset Purchase Agreement)](#apa-asset-purchase-agreement) and [Stock Sale](#stock-sale).

Supermajority Provision is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.

Voting Agreement is a legal and regulatory term relevant to M&A transactions — governing contract rights, regulatory approvals, or post-close obligations.